Cancer Communications
indexed by SCI
BMC

Correlations of P21-activated kinase 1 expression to clinicopathological features of gastric carcinoma and patients’ prognosis
Juan-Xia Wang, Yong-Ning Zhou, Shao-Jing Zou , Tao-Wen Ren , Zhi-Yi Zhang
Department of Hepatopathy, the Second Hospital, Lanzhou University, Lanzhou, Gansu 730030, P. R. China. yongningzhou@sina.com
[Abstract] Background and Objective: Recent studies proved that P21-activated kinase 1 (PAK1) is highly expressed in many kinds of tumor and plays an important role in genesis, development, and metastasis of tumor. We aimed to detect the expression of PAK1 in gastric carcinoma and to analyze its relationship with clinicopathological features and prognosis of gastric carcinoma. Methods: Tissue microarray and immunohistochemical staining were performed to detect PAK1 in paraffin specimens of 189 gastric carcinomas, 54 paracancer tissues, 40 lymph nodes and 30 healthy tissues. Clinicopathologic features and follow-up data of the patients were analyzed by the ?字2 test and the Kaplan-Meier method. Results: Positive rate of PAK1 was 73.0% in gastric carcinoma, 57.4% in paracancer tissues and 23.3% in healthy controls (&KHgr;2 = 29.364, P < 0.05). Expression of PAK1 was significantly correlated with tumor size, tumor differentiation, lymph node metastasis, Lauren classification and invasive depth (all P < 0.05). The positive rate of PAK1 was significantly higher in primary gastric carcinomas than in metastatic lymph nodes (75.0% vs. 52.5%, &KHgr;2 = 4.381, P < 0.05). Survival analysis using the Kaplan-Meier method showed that the expression of PAK1 was a predictor for poor prognosis of the patients with gastric carcinoma (&KHgr;2 = 6.857, P < 0.01). Conclusions: Expression of PAK1 is an early molecular event in the tumorigenesis of gastric carcinoma. It is also closely correlated the development of gastric carcinoma and the patients’ prognosis.
Chinese Journal of Cancer 2010, Volume: 29, Issue 7, Page: 649-654
[ PDF Full-text ]
[Google Scholar]


SHARE THIS ARTICLE


Your Comments

  

 


Comments:


CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China